Masako Wakitani

Comparison of cell lines for stable production of fucose‐negative antibodies with enhanced ADCC

Shinji Hosoi, Kazuya Yamano, Shigeru Iida, 2006, Biotechnology and bioengineering.

Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities.

Tomoaki Nakagawa, Mitsuo Satoh, Masako Wakitani, 2008, Cancer research.

Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity

Shigeru Iida, Mitsuo Satoh, S. Iida, 2004, Biotechnology and bioengineering.

Fucose content of monoclonal antibodies can be controlled by culture medium osmolality for high antibody-dependent cellular cytotoxicity

Shinji Hosoi, Kazuya Yamano, Toshiyuki Suzawa, 2012, Cytotechnology.

Double knockdown of α1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC

Shigeru Iida, Mitsuo Satoh, S. Iida, 2007, BMC Biotechnology.

Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA.

Kazuya Yamano, Shigeru Iida, Mitsuo Satoh, 2004, Biotechnology and bioengineering.

Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa.

Kouhei Tsumoto, Akira Okazaki, Masako Wakitani, 2004, Journal of molecular biology.

IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides.

Shigeru Iida, Mitsuo Satoh, S. Iida, 2005, Journal of immunological methods.